The trading price of Biohaven Ltd (NYSE:BHVN) closed higher on Tuesday, February 11, and closed at $42.53, 11.19% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $38.89 and $44.2803. In examining the 52-week price action we see that the stock hit a 52-week high of $62.21 and a 52-week low of $26.80. Over the past month, the stock has gained 15.82% in value.
Biohaven Ltd, whose market valuation is $4.30 billion at the time of this writing, is expected to release its quarterly earnings report in March. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest BHVN has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 50% Buy.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned BHVN a recommendation rating is 7. Out of them, 0 rate it a Hold, while 7 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Biohaven Ltd (BHVN) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that BHVN’s price is currently 10.13% off the SMA20 and 8.01% off the SMA50. The RSI metric on the 14-day chart is currently showing 62.05, and weekly volatility stands at 5.79%. When measured over the past 30 days, the indicator reaches 5.38%. Biohaven Ltd (NYSE:BHVN)’s beta value is currently sitting at 3.93, while the Average True Range indicator is currently displaying 2.20. With analysts defining $55-$65 as the low and high price targets, we arrive at a consensus price target of $59.5 for the trailing 12-month period. The current price is about -29.32% off the estimated low and -52.83% off the forecast high, based on this estimate. Investors will be thrilled if BHVN’s share price rises to $59.5, which is the median consensus price. At that level, BHVN’s share price would be -39.9% below current price.
To see how Biohaven Ltd stock has been performing in comparison to its peers in the industry, here are the numbers: BHVN stock’s performance was 11.19% in the latest trading, and -9.36% in the past year.
An evaluation of the daily trading volume of Biohaven Ltd (NYSE:BHVN) indicates that the 3-month average is 955.57K. However, this figure has increased over the past 10 days to an average of 0.64.
Currently, records show that 94.90 million of the company’s shares remain outstanding. The insiders hold 12.44% of outstanding shares, whereas institutions hold 87.67%. The stats also highlight that short interest as of 2025-01-31, stood at 9.44 million shares, resulting in a short ratio of 9.7 at that time. From this, we can conclude that short interest is 1048.00 of the company’s total outstanding shares. It is noteworthy that short shares in January were down slightly from the previous month’s figure, which was 9.72 million. However, since the stock’s price has seen 13.87% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
